Bicara Therapeutics
BCAX
#5616
Rank
โ‚น81.62 B
Marketcap
โ‚น1,500
Share price
5.96%
Change (1 day)
N/A
Change (1 year)

Bicara Therapeutics (BCAX) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น44.40 Billion

According to Bicara Therapeutics's latest financial reports the company has โ‚น44.40 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Bicara Therapeutics - Cash on Hand chart (from 2023 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น19.18 B5475.49%
2022-12-31โ‚น0.34 B